Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Mar;219(3):267–274. doi: 10.1097/00000658-199403000-00006

Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience.

R Schoenthaler 1, T L Phillips 1, J Castro 1, J T Efird 1, A Better 1, L W Way 1
PMCID: PMC1243134  PMID: 8147607

Abstract

OBJECTIVE: The authors investigated the combined experience of a single institution in treating bile duct carcinoma during the modern era. SUMMARY BACKGROUND DATA: Bile duct carcinomas are notoriously difficult to cure, with locoregional recurrence the rule, even after radical resection. Adjuvant efforts have included various radiation modalities, with limited success. Recently, charged-particle radiotherapy has also been used in these patients. METHODS: The authors performed a retrospective chart analysis of 129 patients with bile duct adenocarcinomas treated between 1977 and 1987 through the University of California at San Francisco, including 22 patients treated at Lawrence Berkeley Laboratory with the charged particles helium and neon. The minimum follow-up was 5 years. Survival, outcome, and complication results were analyzed. RESULTS: Sixty-two patients were treated with surgery alone (S), 45 patients received conventional adjuvant x-ray radiotherapy (S + X), and 22 were treated with charged particles (S + CP). The median survival times were 6.5, 11, and 14 months, respectively, for the entire group, and 16, 16, and 23 months in patients treated with curative intent. There was a survival difference in patients undergoing total resection compared with debulking (p = 0.05) and minor resections (p = 0.0001). Patients with microscopic residual disease had increased median survival times when they were treated with adjuvant irradiation, most markedly after CP (p = 0.0005) but also with conventional X (p = 0.0109). Patients with gross residual disease had a less marked but still statistically significant extended survival (p = 0.05 for S + X and p = 0.0423 for S + CP) after irradiatio CONCLUSIONS: The mainstay of bile duct carcinoma management was maximal surgical resection in these patients. Postoperative radiotherapy gave patients with positive microscopic margins a significant survival advantage and may be of value in selected patients with gross disease.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beazley R. M., Hadjis N., Benjamin I. S., Blumgart L. H. Clinicopathological aspects of high bile duct cancer. Experience with resection and bypass surgical treatments. Ann Surg. 1984 Jun;199(6):623–636. doi: 10.1097/00000658-198406000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bengmark S., Ekberg H., Evander A., Klofver-Stahl B., Tranberg K. G. Major liver resection for hilar cholangiocarcinoma. Ann Surg. 1988 Feb;207(2):120–125. doi: 10.1097/00000658-198802000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blumgart L. H., Thompson J. N. The management of malignant strictures of the bile duct. Curr Probl Surg. 1987 Feb;24(2):69–127. doi: 10.1016/0011-3840(87)90004-9. [DOI] [PubMed] [Google Scholar]
  4. Boerma E. J. Research into the results of resection of hilar bile duct cancer. Surgery. 1990 Sep;108(3):572–580. [PubMed] [Google Scholar]
  5. Buskirk S. J., Gunderson L. L., Adson M. A., Martinez A., May G. R., McIlrath D. C., Nagorney D. M., Edmundson G. K., Bender C. E., Martin J. K., Jr Analysis of failure following curative irradiation of gallbladder and extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys. 1984 Nov;10(11):2013–2023. doi: 10.1016/0360-3016(84)90198-6. [DOI] [PubMed] [Google Scholar]
  6. Cameron J. L., Pitt H. A., Zinner M. J., Kaufman S. L., Coleman J. Management of proximal cholangiocarcinomas by surgical resection and radiotherapy. Am J Surg. 1990 Jan;159(1):91–98. doi: 10.1016/s0002-9610(05)80612-9. [DOI] [PubMed] [Google Scholar]
  7. Chen G. T., Singh R. P., Castro J. R., Lyman J. T., Quivey J. M. Treatment planning for heavy ion radiotherapy. Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1809–1819. doi: 10.1016/0360-3016(79)90564-9. [DOI] [PubMed] [Google Scholar]
  8. Fogel T. D., Weissberg J. B. The role of radiation therapy in carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys. 1984 Dec;10(12):2251–2258. doi: 10.1016/0360-3016(84)90230-x. [DOI] [PubMed] [Google Scholar]
  9. Kopelson G., Galdabini J., Warshaw A. L., Gunderson L. L. Patterns of failure after curative surgery for extra-hepatic biliary tract carcinoma: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1981 Mar;7(3):413–417. doi: 10.1016/0360-3016(81)90118-8. [DOI] [PubMed] [Google Scholar]
  10. Kopelson G., Harisiadis L., Tretter P., Chang C. H. The role of radiation therapy in cancer of the extra-hepatic biliary system: an analysis of thirteen patients and a review of the literature of the effectiveness of surgery, chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 1977 Sep-Oct;2(9-10):883–894. doi: 10.1016/0360-3016(77)90186-9. [DOI] [PubMed] [Google Scholar]
  11. Langer J. C., Langer B., Taylor B. R., Zeldin R., Cummings B. Carcinoma of the extrahepatic bile ducts: results of an aggressive surgical approach. Surgery. 1985 Oct;98(4):752–759. [PubMed] [Google Scholar]
  12. Mittal B., Deutsch M., Iwatsuki S. Primary cancers of extrahepatic biliary passages. Int J Radiat Oncol Biol Phys. 1985 Apr;11(4):849–854. doi: 10.1016/0360-3016(85)90320-7. [DOI] [PubMed] [Google Scholar]
  13. Ouchi K., Matsuno S., Sato T. Long-term survival in carcinoma of the biliary tract. Analysis of prognostic factors in 146 resections. Arch Surg. 1989 Feb;124(2):248–252. doi: 10.1001/archsurg.1989.01410020122021. [DOI] [PubMed] [Google Scholar]
  14. Proceedings of the American Society for Therapeutic Radiology and Oncology, 30th annual meeting. October 9-14, 1988, New Orleans, Louisiana. Abstracts. Int J Radiat Oncol Biol Phys. 1988;15 (Suppl 1):1–261. [PubMed] [Google Scholar]
  15. Rossi R. L., Heiss F. W., Beckmann C. F., Braasch J. W. Management of cancer of the bile duct. Surg Clin North Am. 1985 Feb;65(1):59–78. doi: 10.1016/s0039-6109(16)43533-4. [DOI] [PubMed] [Google Scholar]
  16. Schoenthaler R., Castro J. R., Halberg F. E., Phillips T. L. Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):75–82. doi: 10.1016/0360-3016(93)90423-s. [DOI] [PubMed] [Google Scholar]
  17. Tompkins R. K., Thomas D., Wile A., Longmire W. P., Jr Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg. 1981 Oct;194(4):447–457. doi: 10.1097/00000658-198110000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yeo C. J., Pitt H. A., Cameron J. L. Cholangiocarcinoma. Surg Clin North Am. 1990 Dec;70(6):1429–1447. doi: 10.1016/s0039-6109(16)45293-x. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES